| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 04/23/2009 | US20090105241 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| 04/23/2009 | US20090105226 administering 7-Benzyloxy-3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine, for the treatment of Alzheimer's disease, cognitive impairment, dementia, epilepsy, neuropathic pain, Parkinson's disease, schizophrenia, attention deficit disorder or depression in humans |
| 04/23/2009 | US20090105221 Muscarinic receptor antagonists |
| 04/23/2009 | US20090105215 Heterocyclic compounds, methods for the preparation thereof, and uses thereof |
| 04/23/2009 | US20090105214 Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes |
| 04/23/2009 | US20090105208 Substituted Piperazines as CB1 Antagonists |
| 04/23/2009 | US20090102356 NOVEL ORGANIC COMPOUND HAVING ELECTRON-TRANSPORTING AND/OR HOLE-BLOCKING PERFORMANCE AND ITS USE AND OLEDs COMPRISING THE COMPOUND |
| 04/23/2009 | CA2702898A1 Inhibitors of c-fms kinase |
| 04/23/2009 | CA2702834A1 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof |
| 04/23/2009 | CA2702563A1 Cgrp antagonists |
| 04/23/2009 | CA2697982A1 1,3,5-trisubstituted triazole derivative |
| 04/23/2009 | CA2694377A1 Imidazolone derivatives, preparation method thereof and biological use of same |
| 04/22/2009 | EP2050744A1 Quinazoline derivatives as angiogenesis inhibitors |
| 04/22/2009 | EP2050450A1 1-Piperidine-2-cyanoimino-1,3-dihydro-2H-benzimidazole derivatives as nociceptin analogs with ORL1 modulating activity for the treatment of pain |
| 04/22/2009 | EP2049547A2 Aza-peptide protease inhibitors |
| 04/22/2009 | EP2049535A1 Alpha-carboline derivatives and methods for preparation thereof |
| 04/22/2009 | EP2049521A2 Novel pyridazine derivatives |
| 04/22/2009 | EP2049514A1 Nitrate esters of piperidines |
| 04/22/2009 | EP2049502A1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 04/22/2009 | EP2049493A2 Compounds suitable as modulators of hdl |
| 04/22/2009 | EP2049486A2 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 04/22/2009 | EP2049115A2 Alkyne-substituted pyridone compounds and methods of use |
| 04/22/2009 | EP1802572B1 Indol derivatives as inhibitors of soluble adenylyl cyclase |
| 04/22/2009 | EP1718632B1 Pyrimidine derivatives as orexin receptor antagonists |
| 04/22/2009 | EP1673354B1 Arylindenopyridines and arylindenopyrimidines and their use as adenosine a2a receptor antagonists |
| 04/22/2009 | EP1592389B1 Piperazine-2-carboxamide derivatives |
| 04/22/2009 | EP1587805B1 Pharmaceutical process and compounds prepared thereby |
| 04/22/2009 | EP1528925B1 Quinazoline derivatives for use in the treatment of cancer |
| 04/22/2009 | EP1381366B1 Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 04/22/2009 | CN101415701A Heterocyclylacrylamide compounds as FABI inhibitors and antibacterial agents |
| 04/22/2009 | CN101415700A Active ingredient combinations with insecticidal properties |
| 04/22/2009 | CN101415687A Binding inhibitor of sphingosine-1-phosphate |
| 04/22/2009 | CN101415682A Substituted enaminocarbonyl compounds |
| 04/22/2009 | CN101415674A Pyrrolidine derivatives as ERK inhibitors |
| 04/22/2009 | CN101414662A Organic electronic transmission and/or positive hole countercheck material, and synthesizing method and purpose thereof |
| 04/22/2009 | CN101414661A Organic electronic transmission and/or positive hole countercheck material, and synthesizing method and purpose thereof |
| 04/22/2009 | CN100481571C Luminescent element material and luminescent element comprising the same |
| 04/22/2009 | CN100480389C Production of polyketides |
| 04/22/2009 | CN100480248C Malonamide derivatives as gamma-secretase inhibitors |
| 04/22/2009 | CN100480242C CDK-inhibitory pyrimidines, and production and use thereof as pharmaceutical agents |
| 04/21/2009 | US7521561 Biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl}-5-methoxyphenyl-carbamoyl)ethyl]piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, asthma |
| 04/21/2009 | US7521545 Diazo coupling benzediazonium salt having nitro group at the p- and/or o-position with 2,3-dihydrobenzofuran derivative to produce compounds such as 1-(4-Nitrophenyl)-2-[2,2,4,6,7-pentamethyl-3-(4-methylphenyl)-2,3-dihydro-1-benzofuran-5-yl]diazene; chemical intermediates; efficient, easy and simple |
| 04/21/2009 | US7521464 drugs have beta-amyloid peptide production inhibitory activity, such as 2-(2-benzo[b]thiophen-4-yl-acetylamino)-N-(5-phenyl-2H-pyrazol-3-yl)-propionamide, useful for treatment of Alzheimer's disease and Down's Syndrome |
| 04/21/2009 | US7521462 4-Amino-piperidine derivatives as monoamine uptake inhibitors |
| 04/21/2009 | US7521453 e.g. 5-Bromo-2-(3-methylisoxazol-5-ylmethylamino)-4-(5-cyclopropyl- 1H-pyrazol-3-ylamino)pyrimidine; anticarcinogenic, antitumor agents; breast, prostate, colon cancer |
| 04/21/2009 | US7521451 e.g. 5,6-dimethyl-3a,4,7,7a-tetrahydro-2-benzofuran-1,3-dione;intravenous, water-soluble compounds useful for manufacturing an anasthetic, sedative agents; side effect reduction |
| 04/21/2009 | US7521448 N-substituted benzimidazolyl c-Kit inhibitors |
| 04/21/2009 | US7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 04/21/2009 | US7521396 processes for their preparation, and to their use as herbicides. |
| 04/21/2009 | US7521250 Fluorescent sensor for phosphate ion and phosphorylated peptide |
| 04/21/2009 | US7521162 photoreceptors comprising electroconductive substrate, charge generating compounds and photoconductors comprising charge transport compounds such as 9-(3-Chloro-2-hydroxypopyl)-3,3'-bicarbazole on the substrates, used for electrography |
| 04/21/2009 | US7521062 Thiosemicarbazones as anti-virals and immunopotentiators |
| 04/21/2009 | US7521004 Chromene compound |
| 04/21/2009 | CA2362003C Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/21/2009 | CA2356263C Aminopyrazole derivatives |
| 04/16/2009 | WO2009047514A1 [1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine compounds and their use |
| 04/16/2009 | WO2009047359A1 Inhibitors of protein kinases |
| 04/16/2009 | WO2009047240A1 Indole derivatives useful as ppar activators |
| 04/16/2009 | WO2009047161A1 Chiral cis-imidazolines |
| 04/16/2009 | WO2009046804A1 Imidazole derivatives |
| 04/16/2009 | WO2009046536A1 Halogenated quinazolinyl nitrofurans as antibacterial agents |
| 04/16/2009 | WO2008108380A3 Pyrrole compounds |
| 04/16/2009 | WO2008103277A3 Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors |
| 04/16/2009 | US20090099233 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
| 04/16/2009 | US20090099199 Organic compounds |
| 04/16/2009 | US20090099196 Chemical Process |
| 04/16/2009 | US20090099186 Inhibitors of viral replication |
| 04/16/2009 | US20090099183 Pyrimidines and uses thereof |
| 04/16/2009 | US20090099181 Sulfoximines as kinase inhibitors |
| 04/16/2009 | US20090099169 Benzofuran Compounds As EP1 Receptor Antagonists |
| 04/16/2009 | US20090099160 4-(4-(Imidazol-4-Yl) Pyrimidin-2-Ylamino) Benzamides as CDK Inhibitors |
| 04/16/2009 | US20090099155 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 04/16/2009 | US20090099143 Tetrahydro-indazole cannabinoid modulators |
| 04/16/2009 | CA2702008A1 Inhibitors of protein kinases |
| 04/16/2009 | CA2701932A1 Chiral cis-imidazolines |
| 04/16/2009 | CA2701568A1 Imidazole derivatives |
| 04/16/2009 | CA2700049A1 Novel compounds as cannabinoid receptor ligands |
| 04/15/2009 | EP2048142A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
| 04/15/2009 | EP2046804A1 Synthesis of diethyl{ i5" (3 -fluorophenyl) -pyridine-2-yl] methyl} phosphonate used in the synthesis of himbacine analogs |
| 04/15/2009 | EP2046784A2 Azolylmethyloxiranes, use thereof for controlling plant pathogenic fungi, and agents containing the same |
| 04/15/2009 | EP2046783A2 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3) |
| 04/15/2009 | EP2046782A2 Imidazolylpyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3) |
| 04/15/2009 | EP2046781A2 Substituted furyl-sulfonylamino(thio)carbonyl-triazoline(thi)ones |
| 04/15/2009 | EP2046780A1 Azolylmethyloxiranes, use thereof for controlling plant pathogenic fungi, and agents containing the same |
| 04/15/2009 | EP2046762A2 Triazolyl phenyl benzenesulfonamides |
| 04/15/2009 | EP2046753A2 Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 04/15/2009 | EP2046738A1 Enantiomerically pure flavone derivatives for the treatment of poliferative disorders and processes for their preparation |
| 04/15/2009 | EP2046147A1 Method of using organic compounds |
| 04/15/2009 | EP1896021B1 Solid pharmaceutical preparation containing (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chroman |
| 04/15/2009 | EP1572686B1 Anthranilic acid amide derivatives and their pharmaceutical use |
| 04/15/2009 | EP1378246B1 sPLA2 INHIBITORS FOR ARTERIOSCLEROSIS |
| 04/15/2009 | CN101410392A Amide substituted quinolines |
| 04/15/2009 | CN101410390A Hydantoin compounds for the treatment of inflammatory disorders |
| 04/15/2009 | CN101410389A Organic compounds |
| 04/15/2009 | CN101410387A Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors |
| 04/15/2009 | CN101410381A Novel 2-substituted benzimidazoles as selective androgen receptor modulators (SARMs) |
| 04/15/2009 | CN101407495A Preparations and uses of isoquinolinium compounds and salts thereof |
| 04/15/2009 | CN101407494A Preparations and uses of isoquinolinium compounds and salts thereof |
| 04/15/2009 | CN101407471A Compound capable of binding S1P receptor and pharmaceutical use thereof |
| 04/15/2009 | CN101406469A Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |